IL113123A - Mono-or bicyclic compounds their preparation and pharmaceutical compositions containing them - Google Patents
Mono-or bicyclic compounds their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL113123A IL113123A IL11312395A IL11312395A IL113123A IL 113123 A IL113123 A IL 113123A IL 11312395 A IL11312395 A IL 11312395A IL 11312395 A IL11312395 A IL 11312395A IL 113123 A IL113123 A IL 113123A
- Authority
- IL
- Israel
- Prior art keywords
- mono
- preparation
- pharmaceutical compositions
- compositions containing
- bicyclic compounds
- Prior art date
Links
- 125000002619 bicyclic group Chemical group 0.000 title 1
- 125000002950 monocyclic group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94104995 | 1994-03-30 | ||
EP95101595 | 1995-02-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL113123A0 IL113123A0 (en) | 1995-06-29 |
IL113123A true IL113123A (en) | 1999-11-30 |
Family
ID=26135552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11312395A IL113123A (en) | 1994-03-30 | 1995-03-24 | Mono-or bicyclic compounds their preparation and pharmaceutical compositions containing them |
Country Status (15)
Country | Link |
---|---|
US (3) | US5589473A (de) |
EP (1) | EP0675122A3 (de) |
JP (1) | JP2695132B2 (de) |
KR (1) | KR950032185A (de) |
CN (2) | CN1114648A (de) |
AU (1) | AU694936B2 (de) |
CA (1) | CA2144499A1 (de) |
CZ (1) | CZ78895A3 (de) |
FI (1) | FI951514A (de) |
HU (1) | HUT72491A (de) |
IL (1) | IL113123A (de) |
NO (1) | NO304024B1 (de) |
NZ (1) | NZ270801A (de) |
RU (1) | RU95104899A (de) |
TW (1) | TW343965B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9601724D0 (en) * | 1996-01-29 | 1996-03-27 | Merck Sharp & Dohme | Therapeutic agents |
US5922883A (en) * | 1996-04-03 | 1999-07-13 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
SI3345895T1 (sl) | 2003-04-11 | 2020-03-31 | Ptc Therapeutics, Inc. | Spojina 1,2,4-oksadiazol benzojske kisline in njena uporaba za supresijo nesmiselne in zdravljenje bolezni |
GB0325830D0 (en) * | 2003-11-05 | 2003-12-10 | Novartis Ag | Organic compounds |
FR2866887A1 (fr) * | 2004-02-27 | 2005-09-02 | Oreal | Para-phenylenediamine secondaire n-heteroaryle, compositon tinctoriale comprenant une telle para-phenylenediamine, procede mettant en oeuvre cette composition et utilisation |
US7329288B2 (en) | 2004-02-27 | 2008-02-12 | L'oreal S.A. | N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof |
GB0500683D0 (en) | 2005-01-13 | 2005-02-23 | Novartis Ag | Organic compounds |
EP1855679B1 (de) * | 2005-01-19 | 2016-06-29 | Merck Sharp & Dohme Corp. | Aminomethyl-beta-sekretase-hemmer zur behandlung von alzheimer |
JP5023054B2 (ja) * | 2005-03-31 | 2012-09-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗バクテリア剤としての二環式ピラゾール化合物 |
EP2387995A1 (de) | 2006-03-30 | 2011-11-23 | PTC Therapeutics, Inc. | Verfahren zur Produktion von funktionellem Protein aus DNA mit Nonsense-Mutation und Behandlung von damit assoziierten Erkrankungen |
US7829709B1 (en) | 2007-08-10 | 2010-11-09 | Marquette University | Cysteine prodrugs to treat schizophrenia and drug addiction |
EP2252596B1 (de) * | 2008-02-07 | 2016-12-28 | Marquette University | Cystein- und cystinprodrugs zur behandlung von schizophrenie und zur verminderung von drogensucht |
US20100048587A1 (en) * | 2008-04-16 | 2010-02-25 | Marquette University | Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings |
WO2012021704A1 (en) * | 2010-08-12 | 2012-02-16 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
KR101604119B1 (ko) | 2011-06-14 | 2016-03-16 | 주식회사 녹십자 | 신규한 c-아릴 안사 sglt2 억제제 |
KR20160007577A (ko) | 2013-05-10 | 2016-01-20 | 카루스 떼라퓨틱스 리미티드 | 신규한 히스톤 디아세틸라제 억제제들 |
CA2942147C (en) | 2014-03-06 | 2022-12-13 | Ptc Therapeutics, Inc. | Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid |
GB201419228D0 (en) * | 2014-10-29 | 2014-12-10 | Karus Therapeutics Ltd | Compounds |
AR106530A1 (es) | 2015-10-30 | 2018-01-24 | Ptc Therapeutics Inc | Métodos para tratar epilepsia |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0535192T3 (da) * | 1991-04-17 | 1996-08-05 | Hoffmann La Roche | Hidtil ukendte DNA-gyraseinhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende dem |
-
1995
- 1995-03-10 TW TW084102306A patent/TW343965B/zh active
- 1995-03-13 CA CA002144499A patent/CA2144499A1/en not_active Abandoned
- 1995-03-15 EP EP95103702A patent/EP0675122A3/de not_active Withdrawn
- 1995-03-20 US US08/407,730 patent/US5589473A/en not_active Expired - Fee Related
- 1995-03-24 NZ NZ270801A patent/NZ270801A/en unknown
- 1995-03-24 IL IL11312395A patent/IL113123A/xx not_active IP Right Cessation
- 1995-03-24 AU AU15070/95A patent/AU694936B2/en not_active Ceased
- 1995-03-24 HU HU9500860A patent/HUT72491A/hu unknown
- 1995-03-29 RU RU95104899/09A patent/RU95104899A/ru unknown
- 1995-03-29 KR KR1019950006839A patent/KR950032185A/ko not_active Application Discontinuation
- 1995-03-29 CZ CZ95788A patent/CZ78895A3/cs unknown
- 1995-03-29 NO NO951210A patent/NO304024B1/no not_active IP Right Cessation
- 1995-03-30 CN CN95104354A patent/CN1114648A/zh active Pending
- 1995-03-30 FI FI951514A patent/FI951514A/fi unknown
- 1995-03-30 JP JP7073217A patent/JP2695132B2/ja not_active Expired - Lifetime
- 1995-10-11 US US08/541,077 patent/US5594135A/en not_active Expired - Fee Related
- 1995-10-11 US US08/540,678 patent/US5665746A/en not_active Expired - Fee Related
-
2000
- 2000-12-01 CN CN00135099A patent/CN1308071A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
HU9500860D0 (en) | 1995-05-29 |
HUT72491A (en) | 1996-05-28 |
FI951514A0 (fi) | 1995-03-30 |
NZ270801A (en) | 1997-01-29 |
US5665746A (en) | 1997-09-09 |
CN1114648A (zh) | 1996-01-10 |
TW343965B (en) | 1998-11-01 |
EP0675122A2 (de) | 1995-10-04 |
JPH07285953A (ja) | 1995-10-31 |
AU1507095A (en) | 1995-10-12 |
AU694936B2 (en) | 1998-08-06 |
US5594135A (en) | 1997-01-14 |
CZ78895A3 (en) | 1995-12-13 |
CA2144499A1 (en) | 1995-10-01 |
JP2695132B2 (ja) | 1997-12-24 |
CN1308071A (zh) | 2001-08-15 |
NO951210L (no) | 1995-10-02 |
US5589473A (en) | 1996-12-31 |
EP0675122A3 (de) | 1997-11-05 |
NO304024B1 (no) | 1998-10-12 |
NO951210D0 (no) | 1995-03-29 |
IL113123A0 (en) | 1995-06-29 |
RU95104899A (ru) | 1997-01-10 |
KR950032185A (ko) | 1995-12-20 |
FI951514A (fi) | 1995-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL115039A (en) | Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them | |
IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
IL122618A0 (en) | Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them | |
IL116775A (en) | Tricyclic azolobenzodiazepines and similar compounds their preparation and pharmaceutical compositions containing them | |
IL105220A0 (en) | Cyclohexanylidene compounds and pharmaceutical compositions containing them | |
IL98176A0 (en) | Bicyclic 1-aza-cycloalkanes,their preparation and pharmaceutical compositions containing them | |
IL121621A0 (en) | Neurotrophic compounds pharmaceutical compositions containing them and their use | |
IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
IL117860A0 (en) | Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them | |
IL119995A0 (en) | Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them | |
IL122293A0 (en) | Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them | |
IL113123A (en) | Mono-or bicyclic compounds their preparation and pharmaceutical compositions containing them | |
AP9701160A0 (en) | Compounds and pharmaceutical compositions containing them | |
IL115905A0 (en) | Sordarin derivatives their preparation and pharmaceutical compositions containing them | |
IL117554A0 (en) | Imidazoquinazolines their preparation and pharmaceutical compositions containing them | |
HUP9901452A3 (en) | Bicyclic-aromatic compounds and pharmaceutical compositions containing them | |
IL117815A0 (en) | Ascomycins their preparation and pharmaceutical compositions containing them | |
IL108073A0 (en) | Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them | |
IL105135A (en) | Carbapenems their preparation their use and pharmaceutical compositions containing them | |
IL115272A0 (en) | Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof | |
IL114623A0 (en) | Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them | |
IL118672A0 (en) | Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them | |
IL119371A0 (en) | Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them | |
ZA941088B (en) | Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them | |
IL117395A0 (en) | Bicyclic compounds preparation thereof and use in pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |